Bumadizone is a carbohydrazide obtained from butylmalonic. It is primarily used as a potent alternative against treatment of rheumatoid arthritis and gout. Additionally, it has utility as a nonsteroidal anti-inflammatory drug. It is majorly administered among highly geriatric population who are at a higher risk of acquiring gout.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the bumadizone market.
Top Impacting Factors
- Rising cases of gout and rheumatoid arthritis among geriatric population in industrialized regions of the world is anticipated to drive market growth for bumadizone sales.
- The disease is further exacerbated when combined with fatal diseases such as malaria and dengue, which result in increase in demand of advanced therapeutic supplements to save lives.
- Need to reduce the burden of the disease globally combined with rising health conscious and high disposable incomes spent on healthcare in developed and newly developing nation further drive the growth for bumadizone calcium tablets.
- Lack of awareness coupled with huge misconceptions associated with new age therapeutics with respect to bumadizone is anticipated to hamper market growth.
Key Market Trends
- North America is anticipated to witness growth of bumadizone market, owing to rising cases of rheumatoid arthritis and gout coupled with growing demand for new age advanced therapeutics for treatment.
- Rising geriatric population in Asia-Pacific is expected to bring huge gains to the market, owing to the presence of high population base coupled with increase in research and development initiatives being undertaken by the government.
- Africa remains mostly underdeveloped with respect to market, owing to presence of inefficient healthcare infrastructure coupled with huge misconceptions for the medication.
- Attempts are being made at development of novel chewable colon targeted tablets of bumadizone for treatment of ulcerative colitis.
- Recent clinical studies carried out at Cancer Research Institute, Fortschritte der Krebsforchung Institute have shown strong evidence of that bumadizone calcium tablets have the capability of preventing numerous types of cancers mainly colorectal cancer.
Key Benefits of the Report
- This study presents the analytical depiction of the bumadizone industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the bumadizone market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Bumadizone Report
- Which are the leading players active in the bumadizone market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the bumadizone market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is bumadizone?
- What is the bumadizone market prediction in the future?
- What are the current trends and predicted trends?
Key Market Segments
- By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Others
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- PharmaxLifesciences
- Paalam Implex Pvt Ltd.
- Tripoot India Ltd
- Dolphin Pharmaceuticals
- Dansons Pharmachem
- Scorp Pharma
- Pan Drugs Ltd, Bianca Pvt Ltd
- Plant Organics Ltd.
- Reine Lifescience
- ANGLE BIOPHARMA